Results 181 to 190 of about 9,896 (218)

Genetic engineering of immunotoxins

1988
Genetic engineering offers many advantages for the 1) production of immunotoxins (ITs) and 2) design of more effective reagents. In Chapter 9, J.R. Murphy discusses the use of genetic engineering to link genes together resulting in chimeric proteins. This review covers the first applications of genetic engineering technology to improve ITs by studying ...
R J, Youle, L, Greenfield, V G, Johnson
openaire   +2 more sources

Immunotoxins

Scientific American, 1984
R J, Collier, D A, Kaplan
openaire   +2 more sources

Immunotoxins in cancer therapy

Current Opinion in Immunology, 1999
Immunotoxins are composed of a protein toxin connected to a binding ligand such as an antibody or growth factor. These molecules bind to surface antigens (which internalize) and kill cells by catalytic inhibition of protein synthesis within the cell cytosol.
openaire   +2 more sources

ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis

European Journal of Surgical Oncology, 2021
Yvonne Andersson, Ben Davidson, Øystein Fodstad   +2 more
exaly  

Immunotoxin enhancers

1988
P, Casellas, F K, Jansen
openaire   +2 more sources

Immunotoxins

2009
Arthur E. Frankel, Jung-Hee Woo, David M. Neville   +2 more
openaire   +2 more sources

Immunotoxins

Clinical Immunotherapeutics, 1994
openaire   +2 more sources

Minimization of aggregation of secreted bivalent anti-human T cell immunotoxin in Pichia pastoris bioreactor culture by optimizing culture conditions for protein secretion

Journal of Biotechnology, 2006
Jung Hee Woo, David M Neville
exaly  

Ocular pharmacokinetics of lens epithelial cell-specific immunotoxin 4197X-RA

Experimental Eye Research, 1992
Craig E Crosson, Dominic Man-Kit Lam, Craig E Crosson   +2 more
exaly  

Saporin Immunotoxins

1998
openaire   +2 more sources